Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
WuXi STA
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
40.0%
+8.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:DominantThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Catalent
Competitor Displacement Rate
20.0%
Competitors are displacing WuXi STA in 20.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Catalent's comprehensive CDMO services and strong R&D partnerships often lead to higher rankings for complex drug development and manufacturing queries.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[catalent.com][lonza.com]⚠️ Identified Vulnerability:Service Breadth
Primary Threat Identified:Catalent
Target Persona:Biopharmaceutical R&D Directors
🚨 Threat Velocity:7/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)